Organization · Venture Capital
Pandect Bioventures
Pandect Bioventures is a venture capital firm based in South San Francisco, California, specializing in seed to Series A funding for early-stage biotech and pharmaceutical companies. They provide comprehensive management support and access to a 40,000 square foot incubator facility.
Overview
What Pandect Bioventures does
What Pandect Bioventures is
Pandect Bioventures is a venture capital firm based in South San Francisco, California, specializing in seed to Series A funding for early-stage biotech and pharmaceutical companies. They provide comprehensive management support and access to a 40,000 square foot incubator facility.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2016
- Approximate age
- About 10 years
- Structured capabilities
- Funder
- Last reviewed
- April 23, 2026
Official channels
Find Pandect Bioventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Pandect Bioventures as a funder
Investment thesis
Pandect Bioventures focuses on funding and supporting early-stage biotech and pharmaceutical companies, particularly from seed to Series A and beyond, leveraging their integrated incubator model.
Focus narrative
Pandect Bioventures invests in early-stage healthcare innovations, particularly in the biotech and pharmaceutical sectors. They employ a rigorous assessment process for investment opportunities and offer customized support to help entrepreneurs navigate the complexities of bringing their innovations to market. Their exclusive relationships with research institutions enhance their ability to leverage emerging discoveries and intellectual property.
Value beyond capital
Pandect Bioventures adds value to its portfolio companies through access to a comprehensive incubator facility, technical advisory support, and strategic guidance from experienced industry professionals. Their integrated approach combines funding with operational assistance, enabling startups to focus on innovation and growth.
Focus and fit
- Stages
- Seed · Series A · Series A+
- Regions
- North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 5
Portfolio context
Circle Pharma: Developing cell permeable macrocyclic peptides for oncology. Invested in 2020. Azkarra Therapeutics: Focused on new oncology therapies based on DNA Damage Response. Invested in 2019. Valitor: A UC Berkeley spin-out working on therapeutic protein modifications. Invested in 2019. Walking Fish Therapeutics: Specializes in B cell medicines and cell-based therapeutics. Invested in 2021. Walden Biosciences: Developing treatments for kidney disease. Invested in 2020.
Common questions
What to know about Pandect Bioventures
Upseed classifies Pandect Bioventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 23, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.